Challenges for Streamlining the Development of Biosimilars: A Japanese Perspective
Clin Pharmacol Ther
.
2023 Jan;113(1):30-36.
doi: 10.1002/cpt.2762.
Epub 2022 Nov 17.
Author
Teruyo Arato
1
Affiliation
1
Clinical Research and Medical Innovation Center, Hokkaido University Hospital, Sapporo, Japan.
PMID:
36397252
DOI:
10.1002/cpt.2762
No abstract available
MeSH terms
Biosimilar Pharmaceuticals*
Drug Industry
East Asian People
Humans
Substances
Biosimilar Pharmaceuticals